Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 99 | Code: MBI-518636

PD-1 and PD-L1 Monoclonal Antibody Market by Products (PD-1, PD-L1), by Applications (Lung Cancer, Liver Cancer, Esophageal Cancer, Gastric Cancer) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global PD-1 and PD-L1 Monoclonal Antibody Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global PD-1 and PD-L1 Monoclonal Antibody market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global PD-1 and PD-L1 Monoclonal Antibody market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Merk
  • Bristol-Myers Squibb Company
  • Roche
  • Pfizer
  • AstraZeneca
  • Junshi Biosciences
  • Innovent
  • Hengrui
  • BeiGene
  • Alphamab Oncology
  • Cstone
  • Akeso

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the PD-1 and PD-L1 Monoclonal Antibody market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • PD-1
  • PD-L1

By Application

  • Lung Cancer
  • Liver Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Nasopharyngeal Carcinoma
  • Head and Neck Cancer
  • Other

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global PD-1 and PD-L1 Monoclonal Antibody market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global PD-1 and PD-L1 Monoclonal Antibody market?

Regional Insights:

The government initiative increasing the development activities of the PD-1 and PD-L1 Monoclonal Antibody market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global PD-1 and PD-L1 Monoclonal Antibody market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 PD-1 and PD-L1 Monoclonal Antibody Market Overview
    1.1 Product Overview and Scope of PD-1 and PD-L1 Monoclonal Antibody
    1.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Type
        1.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 PD-1
        1.2.3 PD-L1
    1.3 PD-1 and PD-L1 Monoclonal Antibody Segment by Application
        1.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Comparison by Application: (2022-2028)
        1.3.2 Lung Cancer
        1.3.3 Liver Cancer
        1.3.4 Esophageal Cancer
        1.3.5 Gastric Cancer
        1.3.6 Nasopharyngeal Carcinoma
        1.3.7 Head and Neck Cancer
        1.3.8 Other
    1.4 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Estimates and Forecasts
        1.4.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2028
        1.4.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2028
        1.4.3 PD-1 and PD-L1 Monoclonal Antibody Market Size by Region: 2017 Versus 2021 Versus 2028
2 PD-1 and PD-L1 Monoclonal Antibody Market Competition by Manufacturers
    2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2017-2022)
    2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global PD-1 and PD-L1 Monoclonal Antibody Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers PD-1 and PD-L1 Monoclonal Antibody Manufacturing Sites, Area Served, Product Type
    2.5 PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends
        2.5.1 PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players Market Share by Revenue
        2.5.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PD-1 and PD-L1 Monoclonal Antibody Retrospective Market Scenario by Region
    3.1 Global PD-1 and PD-L1 Monoclonal Antibody Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global PD-1 and PD-L1 Monoclonal Antibody Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
        3.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
        3.3.2 North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
        3.4.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country
        3.4.2 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Region
        3.5.1 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region
        3.5.2 Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
        3.6.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country
        3.6.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Facts & Figures by Country
        3.7.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country
        3.7.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global PD-1 and PD-L1 Monoclonal Antibody Historic Market Analysis by Type
    4.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    4.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2022)
    4.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2022)
5 Global PD-1 and PD-L1 Monoclonal Antibody Historic Market Analysis by Application
    5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2017-2022)
    5.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merk
        6.1.1 Merk Corporation Information
        6.1.2 Merk Description and Business Overview
        6.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.1.5 Merk Recent Developments/Updates
    6.2 Bristol-Myers Squibb Company
        6.2.1 Bristol-Myers Squibb Company Corporation Information
        6.2.2 Bristol-Myers Squibb Company Description and Business Overview
        6.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
    6.3 Roche
        6.3.1 Roche Corporation Information
        6.3.2 Roche Description and Business Overview
        6.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.3.5 Roche Recent Developments/Updates
    6.4 Pfizer
        6.4.1 Pfizer Corporation Information
        6.4.2 Pfizer Description and Business Overview
        6.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.4.5 Pfizer Recent Developments/Updates
    6.5 AstraZeneca
        6.5.1 AstraZeneca Corporation Information
        6.5.2 AstraZeneca Description and Business Overview
        6.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.5.5 AstraZeneca Recent Developments/Updates
    6.6 Junshi Biosciences
        6.6.1 Junshi Biosciences Corporation Information
        6.6.2 Junshi Biosciences Description and Business Overview
        6.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.6.5 Junshi Biosciences Recent Developments/Updates
    6.7 Innovent
        6.6.1 Innovent Corporation Information
        6.6.2 Innovent Description and Business Overview
        6.6.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.7.5 Innovent Recent Developments/Updates
    6.8 Hengrui
        6.8.1 Hengrui Corporation Information
        6.8.2 Hengrui Description and Business Overview
        6.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.8.5 Hengrui Recent Developments/Updates
    6.9 BeiGene
        6.9.1 BeiGene Corporation Information
        6.9.2 BeiGene Description and Business Overview
        6.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.9.5 BeiGene Recent Developments/Updates
    6.10 Alphamab Oncology
        6.10.1 Alphamab Oncology Corporation Information
        6.10.2 Alphamab Oncology Description and Business Overview
        6.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.10.5 Alphamab Oncology Recent Developments/Updates
    6.11 Cstone
        6.11.1 Cstone Corporation Information
        6.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
        6.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.11.5 Cstone Recent Developments/Updates
    6.12 Akeso
        6.12.1 Akeso Corporation Information
        6.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Description and Business Overview
        6.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Portfolio
        6.12.5 Akeso Recent Developments/Updates
7 PD-1 and PD-L1 Monoclonal Antibody Manufacturing Cost Analysis
    7.1 PD-1 and PD-L1 Monoclonal Antibody Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
    7.4 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 PD-1 and PD-L1 Monoclonal Antibody Distributors List
    8.3 PD-1 and PD-L1 Monoclonal Antibody Customers
9 PD-1 and PD-L1 Monoclonal Antibody Market Dynamics
    9.1 PD-1 and PD-L1 Monoclonal Antibody Industry Trends
    9.2 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
    9.3 PD-1 and PD-L1 Monoclonal Antibody Market Challenges
    9.4 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
10 Global Market Forecast
    10.1 PD-1 and PD-L1 Monoclonal Antibody Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of PD-1 and PD-L1 Monoclonal Antibody by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of PD-1 and PD-L1 Monoclonal Antibody by Type (2023-2028)
    10.2 PD-1 and PD-L1 Monoclonal Antibody Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of PD-1 and PD-L1 Monoclonal Antibody by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of PD-1 and PD-L1 Monoclonal Antibody by Application (2023-2028)
    10.3 PD-1 and PD-L1 Monoclonal Antibody Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of PD-1 and PD-L1 Monoclonal Antibody by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of PD-1 and PD-L1 Monoclonal Antibody by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million) Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million) Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2021 Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) of Key Manufacturers (2017-2022) Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturers (2017-2022) Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers (2017-2022) Table 9. Global Market PD-1 and PD-L1 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Manufacturing Sites and Area Served Table 11. Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global PD-1 and PD-L1 Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units) Table 16. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022) Table 17. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & (US$ Million) Table 18. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2022) Table 19. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units) Table 20. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022) Table 21. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (US$ Million) Table 22. North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022) Table 23. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units) Table 24. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022) Table 25. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units) Table 28. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022) Table 29. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2022) Table 31. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units) Table 32. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022) Table 33. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units) Table 36. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022) Table 39. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units) Table 40. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022) Table 41. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2022) & (US$ Million) Table 42. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Type (2017-2022) Table 43. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2022) & (US$/Unit) Table 44. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Application (2017-2022) Table 45. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022) Table 46. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2022) & (US$ Million) Table 47. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Application (2017-2022) Table 48. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2022) & (US$/Unit) Table 49. Merk Corporation Information Table 50. Merk Description and Business Overview Table 51. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Merk PD-1 and PD-L1 Monoclonal Antibody Product Table 53. Merk Recent Developments/Updates Table 54. Bristol-Myers Squibb Company Corporation Information Table 55. Bristol-Myers Squibb Company Description and Business Overview Table 56. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Table 58. Bristol-Myers Squibb Company Recent Developments/Updates Table 59. Roche Corporation Information Table 60. Roche Description and Business Overview Table 61. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Roche PD-1 and PD-L1 Monoclonal Antibody Product Table 63. Roche Recent Developments/Updates Table 64. Pfizer Corporation Information Table 65. Pfizer Description and Business Overview Table 66. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Table 68. Pfizer Recent Developments/Updates Table 69. AstraZeneca Corporation Information Table 70. AstraZeneca Description and Business Overview Table 71. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Table 73. AstraZeneca Recent Developments/Updates Table 74. Junshi Biosciences Corporation Information Table 75. Junshi Biosciences Description and Business Overview Table 76. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Table 78. Junshi Biosciences Recent Developments/Updates Table 79. Innovent Corporation Information Table 80. Innovent Description and Business Overview Table 81. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Table 83. Innovent Recent Developments/Updates Table 84. Hengrui Corporation Information Table 85. Hengrui Description and Business Overview Table 86. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Table 88. Hengrui Recent Developments/Updates Table 89. BeiGene Corporation Information Table 90. BeiGene Description and Business Overview Table 91. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Table 93. BeiGene Recent Developments/Updates Table 94. Alphamab Oncology Corporation Information Table 95. Alphamab Oncology Description and Business Overview Table 96. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Table 98. Alphamab Oncology Recent Developments/Updates Table 99. Cstone Corporation Information Table 100. Cstone Description and Business Overview Table 101. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Table 103. Cstone Recent Developments/Updates Table 104. Akeso Corporation Information Table 105. Akeso Description and Business Overview Table 106. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Table 108. Akeso Recent Developments/Updates Table 109. Production Base and Market Concentration Rate of Raw Material Table 110. Key Suppliers of Raw Materials Table 111. PD-1 and PD-L1 Monoclonal Antibody Distributors List Table 112. PD-1 and PD-L1 Monoclonal Antibody Customers List Table 113. PD-1 and PD-L1 Monoclonal Antibody Market Trends Table 114. PD-1 and PD-L1 Monoclonal Antibody Market Drivers Table 115. PD-1 and PD-L1 Monoclonal Antibody Market Challenges Table 116. PD-1 and PD-L1 Monoclonal Antibody Market Restraints Table 117. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Type (2023-2028) & (Units) Table 118. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Type (2023-2028) Table 119. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Type (2023-2028) & (US$ Million) Table 120. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Type (2023-2028) Table 121. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Application (2023-2028) & (Units) Table 122. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Application (2023-2028) Table 123. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Application (2023-2028) & (US$ Million) Table 124. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Application (2023-2028) Table 125. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2023-2028) & (Units) Table 126. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Region (2023-2028) Table 127. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Region (2023-2028) & (US$ Million) Table 128. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Region (2023-2028) Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of PD-1 and PD-L1 Monoclonal Antibody Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Type in 2021 & 2028 Figure 3. PD-1 Product Picture Figure 4. PD-L1 Product Picture Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Market Share by Application in 2021 & 2028 Figure 6. Lung Cancer Figure 7. Liver Cancer Figure 8. Esophageal Cancer Figure 9. Gastric Cancer Figure 10. Nasopharyngeal Carcinoma Figure 11. Head and Neck Cancer Figure 12. Other Figure 13. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global PD-1 and PD-L1 Monoclonal Antibody Market Size (2017-2028) & (US$ Million) Figure 15. Global PD-1 and PD-L1 Monoclonal Antibody Sales (2017-2028) & (Units) Figure 16. PD-1 and PD-L1 Monoclonal Antibody Sales Share by Manufacturers in 2021 Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Manufacturers in 2021 Figure 18. The Global 5 and 10 Largest PD-1 and PD-L1 Monoclonal Antibody Players: Market Share by Revenue in 2021 Figure 19. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022) Figure 21. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2021 Figure 22. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2022) Figure 23. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region in 2021 Figure 24. United States PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. France PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. U.K. PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. China PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. India PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. China Taiwan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Indonesia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Thailand PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Malaysia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. UAE PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Sales Market Share of PD-1 and PD-L1 Monoclonal Antibody by Type (2017-2022) Figure 47. Manufacturing Cost Structure of PD-1 and PD-L1 Monoclonal Antibody Figure 48. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody Figure 49. PD-1 and PD-L1 Monoclonal Antibody Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global UAV Propulsion System Market to Grow at a (CAGR) of 11.8% during the Forecast Period 2022-2030

26-Sep-2022 | Semiconductor

As specified in the market business insights exclusive report, the global UAV Propulsion System Market is projected to reach USD 34,258.31 million by 2030. Growth Drivers: Market dynamics are the forces that influence the prices and b ...

Global Autonomous Vehicle Simulation Solution Market to Grow at a (CAGR) of 12.8% during the Forecast Period 2022-2030

24-Sep-2022 | Automobile

As specified in our exclusive report, the global Autonomous Vehicle Simulation Solution Market is projected to reach USD 2,515 Million by 2030. Growth Drivers: Increasing adoption of connected ve ...

Global Active Space Debris Removal Market to Grow at a (CAGR) of 23.9% during the Forecast Period 2022-2030

23-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global  Active Space Debris Removal Market size is projected to reach USD 452.65 million by 2030. According to the European Space Agency (ESA), there have been more than 5,000 launches into space ...

Global Small Arms Market to Grow at a (CAGR) of 4.8% during the Forecast Period 2022-2030

22-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global Small Arms Market is projected to reach USD 12.88 billion by 2030. The defense sector is upgrading weapons and ammunition and adopting more modern weapon systems, and deployments at military bases, i ...

Global RFID in Healthcare Market to Grow at a (CAGR) of 21.5% during the Forecast Period 2022-2030

21-Sep-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global RFID in Healthcare Market is projected to reach USD 12.06 billion by 2030. How RFID is Use in Healthcare Market? RFID applications in healthcare have been positi ...

More News...